Posted by Michael Wonder on 15 Aug 2023
New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS
14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new medicines through the Pharmaceutical Benefits Scheme.
People with chronic migraine who haven’t responded to, or can’t take other preventive medications, will now have affordable access to eptinezumab (Vyepti), which will be listed on the Pharmaceutical Benefits Scheme for the first time.
